Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for ADHD-Related Insomnia
NCT00622427Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ramelteon in Insomnia (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: ADHD Rating Scale at 2 weeks. Started Feb 2008; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00622427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622427.